MYD88 and cardiac hypertrophy: Receptor-interacting serine/threonine-protein kinase 2 (RIP2) deficiency ameliorates cardiac hypertrophy through multiple signaling pathways that reduce TLR4/MyD88/NF-κB activation and MAPKs phosphorylation (134).